|
業務類別
|
Biotechnology |
|
業務概覽
|
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low backpain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform. |
| 公司地址
| 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000 |
| 電話號碼
| +61 396396036 |
| 傳真號碼
| +61 396396030 |
| 公司網頁
| https://www.mesoblast.com |
| 員工數量
| 108 |
| Dr. Eric A. Rose, M.D. |
Director and Chief Medical Officer |
澳元 701.84K |
27/08/2026 |
| Dr. Silviu Itescu, F.A.C.P.,F.R.A.C.P. |
Director and Chief Executive Officer |
澳元 757.50K |
27/08/2026 |
| Mr. Michael Schuster, M.B.A. |
Pharma Partnering |
-- |
27/08/2026 |
| Dr. Paul Simmons, PhD |
Scientific Advisor to the Chief Executive Officer |
-- |
27/08/2026 |
| Ms. Geraldine Storton, B.Sc. ,M.B.A. |
Head of Regulatory Affairs and Quality Management |
-- |
27/08/2026 |
| Ms. Niva Sivakumar, B.Com,L.L.B. |
Joint Company Secretary |
-- |
27/08/2026 |
| Mr. Justin Horst, B.S. |
Head of Manufacturing |
-- |
27/08/2026 |
| Mr. Paul Hughes, B.Bus |
Joint Company Secretary |
-- |
27/08/2026 |
| Dr. Fiona See, PhD |
Senior Vice President and Head of Translational Research |
-- |
27/08/2026 |
| Mr. James O'Brien, M.B.A. |
Chief Financial Officer |
-- |
27/08/2026 |
|
|
| Dr. Eric A. Rose, M.D. |
Director and Chief Medical Officer |
27/08/2026 |
| Mr. William J. Burns, B.A. |
Vice Chairman of the Board |
27/08/2026 |
| Mr. Philip J. Facchina |
Chairman of the Board |
27/08/2026 |
| Ms. Lyn Cobley, BEc |
Independent Director |
27/08/2026 |
| Dr. Silviu Itescu, F.A.C.P.,F.R.A.C.P. |
Director and Chief Executive Officer |
27/08/2026 |
| Mr. Philip Krause, M.D. |
Director |
27/08/2026 |
| Ms. Jane Bell, L.L.B.,L.L.M. |
Independent Director |
27/08/2026 |
| Dr. Gregory George, M.D. |
Director |
27/08/2026 |
|
|
|
|
